US FDA approves the manufacturing of rare lung disease treatment 16-Oct-2018 By Maggie Lynch Therapure was granted approval for the manufacture of Insmed Incorporated’s drug Arikayce at its Missassauga, Canada facility.
As Ebola virus rages, funding is the main constraint for new treatments, scientist says 30-Jul-2014 By Zachary Brennan The worst Ebola virus outbreak in history continues to spread in West Africa as biopharma companies are hampered by funding issues in trying to bring treatments and vaccines to human trials, a scientist says.